Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6859663 | 1.00 | TDP1 (0.49) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6859667 | 1.00 | TDP1 (0.49) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6859655 | 0.94 | TDP1 (0.46) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6859658 | 0.94 | TDP1 (0.46) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6859653 | 0.94 | TDP1 (0.46) | TDP1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL6627710 | 0.93 | TDP1 (0.59) | TDP1LMNAKMT2AKCNQ2CYP3A4 | |
| SCHEMBL6627707 | 0.93 | TDP1 (0.59) | TDP1LMNAKMT2AKCNQ2CYP3A4 | |
| SCHEMBL6627711 | 0.93 | TDP1 (0.59) | TDP1LMNAKMT2AKCNQ2CYP3A4 | |
| SCHEMBL6625908 | 0.92 | MEN1 (0.51) | TDP1SMN1; SMN2LMNAKMT2AKCNQ2 | |
| SCHEMBL30794965 | 0.92 | MEN1 (0.51) | TDP1SMN1; SMN2LMNAKMT2AKCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6831080-B2 | E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents | BRISTOL-MYERS SQUIBB COMPANY | 2004-12-14 | — | — | US | disclosed |